Canton Strategic grants Galvin 53,763 stock options

Q: How many CNTN options did director Sean Galvin receive?

Sean Galvin received options to purchase 53,763 shares of common stock at an exercise price of $1.86 per share. The options were granted under Canton Strategic Holdings' Amended and Restated 2023 Omnibus Equity Incentive Plan as an annual director equity grant.

Q: When do Sean Galvin's CNTN options vest?

13,440 options were vested as of October 23, 2026. Three installments of 13,441 options are to vest on January 11, April 12 and July 13, 2027, each subject to his continuous service as a board member immediately before the applicable vesting date.

The options vest in installments through July 13, 2027, subject to the director's continuous service immediately before each applicable vesting date.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Canton Strategic Holdings, Inc. director Sean Galvin received an annual director equity grant of options to purchase 53,763 shares of common stock at an exercise price of $1.86 per share. Of the options, 13,440 were vested as of October 23, 2026; three further installments of 13,441 options are to vest on January 11, April 12 and July 13, 2027, subject to his continuous service as a board member immediately before each vesting date. The options expire October 23, 2036.

Insider Trade Summary

Grant/Award: 53,763 shares

Grant/Award 1 txn

Insider Galvin Sean

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) ^{F2, F1}	53,763	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 53,763 contracts (Direct)

Footnotes (2)

F1. Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 13,440 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on January 11, 2027, (iii) 13,441 shares shall vest on April 12, 2027, and (iv) the remaining 13,441 shares shall vest on July 13, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.
F2. This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Key Figures

Options granted: 53,763 options Exercise price: $1.86 per share Options vested: 13,440 options +4 more

7 metrics

Options granted 53,763 options Annual director equity grant on October 23, 2026

Exercise price $1.86 per share Option to purchase common stock

Options vested 13,440 options Vested as of October 23, 2026

Scheduled vesting installment 13,441 options To vest January 11, 2027, subject to continuous service immediately before vesting

Scheduled vesting installment 13,441 options To vest April 12, 2027, subject to continuous service immediately before vesting

Scheduled vesting installment 13,441 options To vest July 13, 2027, subject to continuous service immediately before vesting

Option expiration date October 23, 2036 Expiration date of the option

Key Terms

Amended and Restated 2023 Omnibus Equity Incentive Plan, Non-Employee Director Compensation Policy, continuous service

3 terms

Amended and Restated 2023 Omnibus Equity Incentive Plan technical

"under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan"

Non-Employee Director Compensation Policy technical

"pursuant to the Issuer's Non-Employee Director Compensation Policy"

continuous service technical

"subject to the Reporting Person's continuous service as a member"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CNTN options did director Sean Galvin receive?

Sean Galvin received options to purchase 53,763 shares of common stock at an exercise price of $1.86 per share. The options were granted under Canton Strategic Holdings' Amended and Restated 2023 Omnibus Equity Incentive Plan as an annual director equity grant.

When do Sean Galvin's CNTN options vest?

13,440 options were vested as of October 23, 2026. Three installments of 13,441 options are to vest on January 11, April 12 and July 13, 2027, each subject to his continuous service as a board member immediately before the applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/27/2026 - 06:43 PM EDT Accepted by SEC EDGAR 10/27/2026 - 06:43 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galvin Sean

(Last)

(First)

(Middle)

CANTON STRATEGIC HOLDINGS, INC

1460 BROADWAY

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Canton Strategic Holdings, Inc. [ CNTN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$1.86	10/23/2026		A		53,763		⁽¹⁾	10/23/2036	Common Stock	53,763	⁽²⁾	53,763	D

Explanation of Responses:

1. Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 13,440 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on January 11, 2027, (iii) 13,441 shares shall vest on April 12, 2027, and (iv) the remaining 13,441 shares shall vest on July 13, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

2. This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

	/s/ Sean Galvin	10/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR